-
T288413-5mgSelective ALK degrader.
-
-
T287490-10mgNegative control forTL 12-186.
-
T287490-1mgNegative control forTL 12-186.
-
T287490-25mgNegative control forTL 12-186.
-
T287490-5mgNegative control forTL 12-186.
-
T658922-100mgTLR4-IN-C34-C2-amide-C6-OH is a linker that incorporates TLR4 inhibitor TLR4-IN-C34. TLR4-IN-C34 inhibits TLR4 in enterocytes and macrophages, and reduces systemic inflammation in mouse models of endotoxemia and necrotizing
-
T658922-25mgTLR4-IN-C34-C2-amide-C6-OH is a linker that incorporates TLR4 inhibitor TLR4-IN-C34. TLR4-IN-C34 inhibits TLR4 in enterocytes and macrophages, and reduces systemic inflammation in mouse models of endotoxemia and necrotizing
-
T658922-500mgTLR4-IN-C34-C2-amide-C6-OH is a linker that incorporates TLR4 inhibitor TLR4-IN-C34. TLR4-IN-C34 inhibits TLR4 in enterocytes and macrophages, and reduces systemic inflammation in mouse models of endotoxemia and necrotizing
-
T658922-50mgTLR4-IN-C34-C2-amide-C6-OH is a linker that incorporates TLR4 inhibitor TLR4-IN-C34. TLR4-IN-C34 inhibits TLR4 in enterocytes and macrophages, and reduces systemic inflammation in mouse models of endotoxemia and necrotizing
-
T659307-10mgTMX-4113 is a degrader of phosphodiesterase 6D ( PDE6D ) and casein kinase 1α ( CK1α ). TMX-4113 can be used for the research of cancer.Appearance:SolidIC50&: Target:PDE6D CK1αIn Vitro:TMX-4113 (compound 21: 1 μM: 4 h) shows a high degradation
-
T659307-25mgTMX-4113 is a degrader of phosphodiesterase 6D ( PDE6D ) and casein kinase 1α ( CK1α ). TMX-4113 can be used for the research of cancer.Appearance:SolidIC50&: Target:PDE6D CK1αIn Vitro:TMX-4113 (compound 21: 1 μM: 4 h) shows a high degradation